ClinicalTrials.Veeva

Menu

A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block

A

Ain Shams University

Status and phase

Completed
Phase 1

Conditions

Upper Limb Surgery
Hand Surgery

Treatments

Drug: Articaine
Drug: Bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT04189198
Articaine versus bupivacain

Details and patient eligibility

About

Effect of 2%Articaine versus 5%bupivacaine in pt undergoing short duration surgery in upper limb

Full description

The investigator aim to compare Articaine 2% versus bupivacaine 0.5% in patient undergoing upper limb procedure under ultrasound guided supraclavicular block as regard onset and duration of sensory and motor block

Enrollment

60 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • upper limb surgery
  • ganglion removal
  • k wiring
  • Carapal tunnel

Exclusion criteria

  • Coagulopathy.
  • infection at site of injection.
  • patient refusal.
  • hypersensitivity.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups

Articaine group
Experimental group
Description:
Patients in this group are assigned to recieve 30 ml of Articaine 2%
Treatment:
Drug: Articaine
Bupivacaine
Experimental group
Description:
Patients in this group are assigned to recieve 30 ml of bupivacaine 0.5%
Treatment:
Drug: Bupivacaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems